QQ客服 官方微博 反馈留言

浏览/检索结果: 共11条，第1-10条 帮助 限定条件 发表日期：2018     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Primary breast diffuse large B-cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure 期刊论文 CANCER SCIENCE, 2018, 卷号: 109, 期号: 12 作者:  Zhang, Wei;  Jia, Jing;  Bai, Ou;  Yang, Sheng;  Liang, Rong 收藏  |  浏览/下载：42/0  |  提交时间：2019/12/05 breast  diffuse large B-cell lymphoma  radiotherapy  relapse  rituximab   Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial 期刊论文 BLOOD, 2018, 卷号: 132 作者:  Wang, Aihua;  Hilger, James;  Huang, Jane;  Novotny, William;  Osman, Muhtar 收藏  |  浏览/下载：24/0  |  提交时间：2019/12/05 Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 期刊论文 BLOOD, 2018, 卷号: 132 作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng 收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05 Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 会议论文 作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial 会议论文 作者:  Song, Yuqin;  Zhou, Keshu;  Zou, Dehui;  Zhou, Jianfeng;  Hu, Jianda 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05 AUGMENT: A Phase III Randomized Study of Lenalidomide Plus Rituximab (R-2) Vs Rituximab/Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma 会议论文 作者:  Leonard, John P.;  Trneny, Marek;  Izutsu, Koji;  Fowler, Nathan H.;  Hong, Xiaonan 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05 Primary breast diffuse large B-cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure 期刊论文 2018, 卷号: 109, 期号: 12, 页码: 3943-3952 作者:  Hu, Shaoxuan;  Song, Yuqin;  Sun, Xiuhua;  Su, Liping;  Zhang, Wei 收藏  |  浏览/下载：18/0  |  提交时间：2020/01/03 breast  diffuse large B-cell lymphoma  radiotherapy  relapse  rituximab   Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial 期刊论文 2018, 卷号: 132 作者:  Song, Yuqin;  Zhou, Keshu;  Zou, Dehui;  Zhou, Jianfeng;  Hu, Jianda 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03 Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 期刊论文 2018, 卷号: 132 作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03 Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial 会议论文 BLOOD, 2018-11-29 作者:  Song, Yuqin;  Zhou, Keshu;  Zou, Dehui;  Zhou, Jianfeng;  Hu, Jianda 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03